Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1/2 1Phase 1 1

Status

Completed 13Unknown 9Recruiting 3Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 33Leukemia, Myeloid, Acute 26Colorectal Neoplasms 26Neoplasms 24Neoplasm Metastasis 23Recurrence 22Multiple Myeloma 22Advanced Solid Tumors 19Lymphoma, B-Cell 18Breast Neoplasms 18Lung Neoplasms 14Pancreatic Neoplasms 13Glioblastoma 13Melanoma 12Hematologic Neoplasms 12Carcinoma, Hepatocellular 12Lymphoma 11Glioma 11Brain Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Advanced Solid Tumor 10Prostatic Neoplasms 9Ovarian Neoplasms 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 8Esophageal Neoplasms 8

Interventions

palbociclib 1Sirolimus 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Advanced Breast Cancer × Clear all
NCT06941142 2025-04-23

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Not yet recruiting
382 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡